All for marketing, all for service marketing. On the eighth day of the Lunar New Year, Cheng Yi Pharmaceutical held a one-day "closed door meeting" to study how to achieve a "good start" after the start of spring. In the morning, a symposium was held for middle and senior management to listen to opinions and suggestions on improving the competitiveness of the enterprise; In the afternoon, a marketing work symposium will be held to gather the product line managers of the marketing center and sales department managers of various provinces and regions, listen to the sales report for the first quarter, deploy a "good start" campaign plan for the whole year, and sound the signal of advancing performance to a new level.
Yan Yiyi, Chairman of Cheng Yi Pharmaceutical, gave a mobilization speech for "Annual Red"
Since 2021, Cheng Yi Pharmaceutical has been focusing on the research and development of new drugs, strengthening investment and technological transformation, and promoting mergers and acquisitions to expand the chain, laying the groundwork for the new year's performance to reach a new level. In terms of research and development, the company has focused on building an "innovative highland" for marine biopharmaceuticals. Currently, there are more than 20 new products under research, among which glucosamine hydrochloride capsules, a medication for treating bone and joints, have achieved the largest sales in China; In terms of technological transformation, the company is embarking on a 1000 ton super fish oil EPA project, while focusing on creating a "digital highland" for pharmaceutical intelligent manufacturing. It has been awarded the title of a pilot demonstration enterprise for the integration of new generation information technology and manufacturing in Zhejiang Province; In terms of mergers and acquisitions, the company acquired three more companies in Guangzhou and Yunnan in 2021, expanding the food and health products industry. As of now, Cheng Yi Pharmaceutical has 6 subsidiaries, forming seven major sectors including pharmaceutical preparations, raw materials, marine medicine, biopharmaceuticals, traditional Chinese medicine, medical devices, and the big health industry. It has become a leading enterprise in Wenzhou's life and health industry, creating a "development highland" for the life and health industry.
In 2021, the sales of Vergu Hydrochloride Glucosamine Capsules for the treatment of bone and joint diseases continued to be the first winning bidder in the national centralized procurement, leading the country in sales. At the end of last year, they also obtained an NPN certificate that could enter the Canadian market. Li Quan Tolasemi Injection has passed the national consistency evaluation for the first time, and the new product aspartate ornithine has been developed for eight years and obtained national approval. The production conditions for the Super Fish Oil EPA project have been met, laying a solid foundation for sustainable sales.
At the marketing symposium, the company recognized four managers: Yu Haidao, the manager of Yunnan Province, Wang Yong, the manager of Shandong Province, Cai Jianguo, the manager of Henan Province, and Ji Dengpan, the manager of Hunan Province
Provincial Sales Excellence Award and Development Award. Managers from various provinces and regions have expressed their willingness to contribute to the "good start" of the first quarter. In response to the relevant questions raised by everyone, the general manager and chairman of the board of directors have studied them on the spot and provided satisfactory answers.
During a discussion with various marketing experts, General Manager Zhao Chunjian pointed out that at the beginning of the year, the company had already formulated production and operation tasks for 2022 and implemented them in detail. Each product line manager should go deep into the market, collect information as soon as possible, take measures as soon as possible, and implement policies as soon as possible to overcome the adverse effects of the epidemic, and make every effort to ensure that revenue and net profit continue to grow; We must unleash the fighting spirit of the Corps, fight hard for a quarter, and ensure a successful start.
Luo Feiyue, Executive Vice General Manager of Cheng Yi Pharmaceutical and General Manager of Marketing Center, Deploys the "Annual Red" Campaign Plan
The chairman of the company, Yan Yiyi, thanks all the staff of the marketing center for their hard work in increasing the company's performance and delivering satisfactory answers to society over the past year. He requested that the marketing tasks in the first quarter be overfulfilled, in order to establish confidence, broaden our eyes, pay attention to details, and enhance the combat effectiveness of the marketing team. The company should establish the concept of "everything serves marketing" and strive to achieve a "good start and a good year" in 2022.
Article source: Dazhong Securities News